These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35822903)

  • 1. IPMK modulates hepatic glucose production and insulin signaling.
    Jung IR; Anokye-Danso F; Jin S; Ahima RS; Kim SF
    J Cell Physiol; 2022 Aug; 237(8):3421-3432. PubMed ID: 35822903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inositol polyphosphate multikinase modulates free fatty acids-induced insulin resistance in primary mouse hepatocytes.
    Jung IR; Ahima RS; Kim SF
    J Cell Biochem; 2023 Nov; 124(11):1695-1704. PubMed ID: 37795573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zbtb7c is a critical gluconeogenic transcription factor that induces glucose-6-phosphatase and phosphoenylpyruvate carboxykinase 1 genes expression during mice fasting.
    Choi WI; Yoon JH; Song JY; Jeon BN; Park JM; Koh DI; Ahn YH; Kim KS; Lee IK; Hur MW
    Biochim Biophys Acta Gene Regul Mech; 2019 Jun; 1862(6):643-656. PubMed ID: 30959128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice.
    De Souza CT; Frederico MJ; da Luz G; Cintra DE; Ropelle ER; Pauli JR; Velloso LA
    J Physiol; 2010 Jun; 588(Pt 12):2239-53. PubMed ID: 20421289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
    Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bioinformatics and transcriptomics based investigation reveals an inhibitory role of Huanglian-Renshen-Decoction on hepatic glucose production of T2DM mice via PI3K/Akt/FoxO1 signaling pathway.
    Wu F; Shao Q; Xia Q; Hu M; Zhao Y; Wang D; Fang K; Xu L; Zou X; Chen Z; Chen G; Lu F
    Phytomedicine; 2021 Mar; 83():153487. PubMed ID: 33636476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic p38α MAPK controls gluconeogenesis via FOXO1 phosphorylation at S273 during glucagon signalling in mice.
    Yang W; Liao W; Li X; Ai W; Pan Q; Shen Z; Jiang W; Guo S
    Diabetologia; 2023 Jul; 66(7):1322-1339. PubMed ID: 37202506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes.
    Valverde AM; Burks DJ; Fabregat I; Fisher TL; Carretero J; White MF; Benito M
    Diabetes; 2003 Sep; 52(9):2239-48. PubMed ID: 12941762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GCN5L1 modulates cross-talk between mitochondria and cell signaling to regulate FoxO1 stability and gluconeogenesis.
    Wang L; Scott I; Zhu L; Wu K; Han K; Chen Y; Gucek M; Sack MN
    Nat Commun; 2017 Sep; 8(1):523. PubMed ID: 28900165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.
    Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y
    Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosaminoglycan from Apostichopus japonicus inhibits hepatic glucose production via activating Akt/FoxO1 and inhibiting PKA/CREB signaling pathways in insulin resistant hepatocytes.
    Chen Y; Liu H; Wang Y; Yang S; Yu M; Jiang T; Lv Z
    Food Funct; 2019 Nov; 10(11):7565-7575. PubMed ID: 31687719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
    Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV
    Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of gluconeogenesis in primary hepatocytes by stromal cell-derived factor-1 (SDF-1) through a c-Src/Akt-dependent signaling pathway.
    Liu HY; Wen GB; Han J; Hong T; Zhuo D; Liu Z; Cao W
    J Biol Chem; 2008 Nov; 283(45):30642-9. PubMed ID: 18786922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of renal sympathetic denervation on hepatic glucose metabolism and blood pressure in a rat model of insulin resistance.
    Chen W; Chang Y; He L; Jian X; Li L; Gao L; Yang Y; Zeng M; Liu H; Zhao AZ; Yang G
    J Hypertens; 2016 Dec; 34(12):2465-2474. PubMed ID: 27512967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of PTP1B restores IRS1-mediated hepatic insulin signaling in IRS2-deficient mice.
    González-Rodríguez A; Mas Gutierrez JA; Sanz-González S; Ros M; Burks DJ; Valverde AM
    Diabetes; 2010 Mar; 59(3):588-99. PubMed ID: 20028942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-19a mediates gluconeogenesis by targeting PTEN in hepatocytes.
    Dou L; Wang S; Huang X; Sun X; Zhang Y; Shen T; Guo J; Man Y; Tang W; Li J
    Mol Med Rep; 2018 Mar; 17(3):3967-3971. PubMed ID: 29257352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inositol polyphosphate multikinase in adipocytes is dispensable for regulating energy metabolism and whole body metabolic homeostasis.
    Lee S; Beon J; Kim MG; Kim S
    Am J Physiol Endocrinol Metab; 2020 Aug; 319(2):E401-E409. PubMed ID: 32634320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamine administration promotes hepatic glucose homeostasis through regulating the PI3K/Akt pathway in high-fat diet-induced obese mice with limb ischemia.
    Pitaloka DMI; Ko CH; Lin MT; Yeh SL; Yeh CL
    Nutr Res; 2019 Aug; 68():45-53. PubMed ID: 31419579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bradykinin inhibits hepatic gluconeogenesis in obese mice.
    Barros CC; Haro A; Russo FJ; Schadock I; Almeida SS; Reis FC; Moraes MR; Haidar A; Hirata AE; Mori M; Bacurau RF; Würtele M; Bader M; Pesquero JB; Araujo RC
    Lab Invest; 2012 Oct; 92(10):1419-27. PubMed ID: 22868909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oncoprotein HBXIP suppresses gluconeogenesis through modulating PCK1 to enhance the growth of hepatoma cells.
    Shi H; Fang R; Li Y; Li L; Zhang W; Wang H; Chen F; Zhang S; Zhang X; Ye L
    Cancer Lett; 2016 Nov; 382(2):147-156. PubMed ID: 27609066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.